Skip to main content
. 2020 Nov 12;12(11):3353. doi: 10.3390/cancers12113353

Table 4.

Clinical trials of MCL1 inhibitors.

Clinicaltrials.Gov Identifier Other Study ID Numbers Intervention Route of Administration Disease Study Phase(s)
NCT03218683 D6910C00001 AZD-5991 IV R/R hematologic malignancies 1
NCT02992483 CMIK665 × 2101, 2016-003624-22 MIK665 IV R/R MM, R/R NHL 1
NCT02675452 20150161, 2015-004777-32 AMG-176 IV R/R MM 1
NCT03465540 20170173 AMG-397 PO R/R MM, R/R NHL 1